Angiopoetin-2 (ANG-2) may be an important marker of juvenile idiopathic arthritis (JIA), according to research presented at the 2017 Annual European Congress of Rheumatology (EULAR), held June 14-17 in Madrid, Spain.

Researchers from the department of pediatric rheumatology at the Medical University of Lodz, in Poland, evaluated ANG-2 scrum and the correlation between synovial fluid levels in patients with JIA and degree of ultrasound-detected synovial angiogenesis to further clarify ANG-2’s value as a disease activity marker.

They measured serum levels in 63 patients between the age of 1.5 and 17 with JIA and 31 age-matched healthy controls. They also collected synovial fluid from 17 patients with JIA, and assessed disease activity with the Juvenile Arthritis Disease Activity Score-27 (JADAS-27). 


Continue Reading

They also performed ultrasound examinations of inflamed joints in all patients with JIA, and evaluated synovial angiogenesis by both power Doppler ultrasonography (PDUS) and the fourth grade vascularity scale (0-3).

According to the researchers, ANG-2 serum levels were higher in children with JIA compared with healthy controls (5.5±1.2 ng/ml vs 1.9±1.4 ng/ml). Serum concentration of ANG-2 in children with JIA increased with disease activity (1.4±0.9 ng/ml vs 1.4±1.0 ng/ml vs 1.8±2.2 ng/ml), whereas ANG-2 levels in the synovial fluid were the highest in children with high disease activity (3.4±2.5 ng vs 12.5±9.5 ng/ml vs 26.4±9.0 ng/ml, P <.05).

In addition, ANG-2 concentration in serum correlates with the synovial vascularization obtained by PDUS (0-3; 1.5±0.8 ng/ml vs 1.3±0.9 ng/ml vs 1.5±1.0 ng/ml vs 13.2±8.7 ng/ml, P <.01). The researchers also observed a similar pattern for ANG-2 levels in synovial fluid and PDUS grade (0-3; 3.8±1.0 ng/ml vs 5.1±4.1 ng/ml vs 13.5±2.0 ng/ml, P <.01), leading them to confirm not only ANG-2’s value as a marker for JIA, but also that when combined with ultrasound examination ANG-2 can help lead to appropriate therapy.

follow @RheumAdvisor

Related Articles

Reference

Swidrowska-Jaros J, Smolewska E. Angiopoetin-2 as a new valuable marker of disease activity in children with juvenile idiopathic arthritis. Presented at: 2017 Annual European Congress of Rheumatology (EULAR); June 14-17, 2017; Madrid, Spain. doi:10.1136/annrheumdis-2017-eular.1185